A phase 3, open-label, multicenter study of a 6-month pre-mixed depot formulation of leuprolide mesylate in advanced prostate cancer patients

Neal D. Shore, I. Minčík, Mark DeGuenther, Vladimír Študent, Mindaugas Jievaltas, Jitka Patockova, Kelle Simpson, Chu-Hsuan Hu, Shih‐Tsung Huang, Yuhua Li,

World Journal of Urology · 2019 · 10 citations · 13 references

DOIFull text

Open access

References

13